Study to Compare the Safety and Efficacy of UB-851 and Eprex®

NCT02708914 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
269
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UBI Pharma Inc.